Described herein are pharmaceutical packaging methods which prevent oxidative degradation of morphine, hydromorphone, promethazine together with other oxygen-sensitive prescription drugs, such methods including a syringe having an oxygen permeable suggestion cap, a hermetically sealed oxygen barrier blister packaging with very minimal permeability